ESC NEUBASE THERAPEUTI
NBSE.ESC----
ESC NEUBASE THERAPEUTI (NBSE.ESC)
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- MorningStar · May 14 at 04:45 AM
Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-Girdle Muscular Dystrophy
- MorningStar · May 4 at 02:05 AM
Valerio Therapeutics Announces the Launch of InVimmune, a New Company Dedicated to Developing Differentiated in Vivo Cell Therapy Approaches
- Pharmaceutical Technology · Apr 28 at 05:22 AM
Seaport and Hemab target $180m IPOs as biotech listings accumulate
- GuruFocus · Apr 22 at 01:16 PM
Eli Lilly Moves To Strengthen Cancer Pipeline
- StockTitan · Apr 16 at 10:30 AM
Kailera Therapeutics Announces Pricing of Initial Public Offering | KLRA Stock News
- MorningStar · Apr 9 at 12:30 AM
Egetis Appoints Tiago Nunes as Chief Medical Officer
